Cargando…
Targeting CK2 in cancer: a valuable strategy or a waste of time?
CK2 is a protein kinase involved in several human diseases (ranging from neurological and cardiovascular diseases to autoimmune disorders, diabetes, and infections, including COVID-19), but its best-known implications are in cancer, where it is considered a pharmacological target. Several CK2 inhibi...
Autores principales: | Salvi, Mauro, Borgo, Christian, Pinna, Lorenzo A., Ruzzene, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555718/ https://www.ncbi.nlm.nih.gov/pubmed/34716311 http://dx.doi.org/10.1038/s41420-021-00717-4 |
Ejemplares similares
-
Protein kinase CK2: a potential therapeutic target for diverse human diseases
por: Borgo, Christian, et al.
Publicado: (2021) -
Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells
por: Zonta, Francesca, et al.
Publicado: (2021) -
Role of protein kinase CK2 in antitumor drug resistance
por: Borgo, Christian, et al.
Publicado: (2019) -
Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells
por: Alcaraz, Estefania, et al.
Publicado: (2020) -
Exploring the CK2 Paradox: Restless, Dangerous, Dispensable
por: Franchin, Cinzia, et al.
Publicado: (2017)